CCNF and breast carcinoma: In addition, CCNF was an adverse prognostic factor in terms of distant metastasis-free survival (DMFS) in patients with breast cancer and for distant relapse-free survival (DRFS) in patients with soft tissue liposarcoma (P<0.01) (Figure 3E).